Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Skin and Stem Cell
  4. Articles

  5. Platelet-Rich Plasma for Musculoskeletal Disorders: No Infection Reported in Daily Practice
  6. Scopus by Title (Ref)

Journal of Skin and Stem Cell

The Official Journal of Skin and Stem Cell Research Center

Home
Current IssueAll IssuesIn PressSearchAccepted Manuscripts
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesPublication Ethics and Malpractice StatementSupportReviewer and AE Registration FormJournal MetricsContact UsOpen Peer Review (OPR)
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Autologous Platelet-Rich Plasma Therapy in Complex Treatment of Musculoskeletal Disorders: a Review

- Nurlygaianov R.Z. , et al.

2. Editorial Commentary: Waiting at Least 1 Month After an Intra-articular Corticosteroid Injection for Performing a Knee, Shoulder, and Hip Arthroscopy Could Minimize the Risk for Postoperative Infection: Platelet-Rich Plasma Is an Alternative

- Paschos N.K. , et al.

3. Editorial Commentary: Platelet-Rich Plasma May Be Superior to Corticosteroid Injection for Rotator Cuff Disease Because of Improved Chance of Healing, Longer-Lasting Pain Relief, and No Detriment if Surgery Is Needed

- Brand J.C. , et al.

HomeInstructions

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Reviewer and AE Registration Form
  • Journal Metrics
  • Contact Us
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.